Circulating thrombomodulin and vascular cell adhesion molecule-1 and renal vascular lesion in patients with lupus nephritis

Lupus

Volumn 17, Issue 8, 2008, Pages 720-726

  Yao, G H ^a   Liu, Zhi Hong ^a   Zhang, X ^a   Zheng, C X ^a   Chen, H P ^a   Zeng, C H ^a   Li, L S ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

E selectin; Lupus nephritis; Thrombomodulin; Vascular cell adhesion molecule 1; Vascular lesion

Indexed keywords

CARDIOLIPIN ANTIBODY; COMPLEMENT; CORTICOSTEROID; CREATININE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRYOGLOBULINEMIA; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATURIA; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RENOVASCULAR DISEASE; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; BIOLOGICAL MARKERS; CAPILLARIES; E-SELECTIN; FEMALE; HUMANS; KIDNEY; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MALE; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 49749125977     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308089441     Document Type: Article

References (25)

1. Mok, CC. Prognostic factors in lupus nephritis. Lupus 2005; 14: 39-44.
2. Banfi, G, Bertani, T, Boeri, V, et al. Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Am J Kidney Dis 1991; 18: 240-248.
3. Appel, GB, Pirani, CL, D'Agall, V. Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 1994; 4: 1499-1515.
4. Chong, AY, Blann, AD, Lip, GYH. Assessment of endothelial damage and dysfunction: observations in relation to heart failure. Q J Med 2003; 96: 253-267.
5. Kiraz, S, Ertenli, I, Benekli, M, et al. Clinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: evidence for a prothrombotic state. Lupus 1999; 8: 737-741.
6. Ohdama, S, Takano, S, Miyake, S, Kubota, T, Sato, K, Aoki, N. Plasma thrombomodulin as a marker of vascular injuries in collagen vascular diseases. J Clin Pathol 1994; 101: 109-113.
7. Wada, H, Ohiwa, M, Kaneko, T, et al. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Am J Hematol 1992; 39: 20-24.
8. Ho, CY, Wong, CK, Li, EK, Tam, LS, Lam, CWK. Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesiong molecule-1 in patients with systemic lupus erythematosus. Rheumatology 2003; 42: 117-122.
9. Lai, KN, Leung, JCK, Lai, KB, Wong, KC, Lai, CKW. Upregulation of adhesion molecule expression on endothelial cells by anti-DNA autoantibodies in systemic lupus erythematosus. Clin Immunol Immunopathol 1996; 81: 229-238.
10. Di Lorenzo, G, Pacor, ML, Mansueto, P, et al. Circulating levels of soluble adhesion molecules in patients with ANCA-associated vasculitis. J Nephrol 2004; 17: 800-807.
11. Hochberg, MC. Updating the American College of Rheumatology revised criteria for classifications of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725-1726.
12. Weening, JJ. D'Agati, D, Schwartz, M, et al. The classification of glomerulonephritis in systemic lupus erythematosus. Kidney Int 2004; 65: 521-530.
13. Bombardier, C, Gladman, DD, Urowitz, MB, Caron, D, Chang, CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
14. Boehme, MWJ, Nawroth, PP, Kling, E, et al. Serum thrombomodulin: a novel marker of disease activity in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 572-577.
15. Frijns, R, Fijnheer, R, Schiel, A, Donders, R, Sixma, J, Derksen, R. Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers. J Rheumtol 2001; 28: 514-519.
16. Rustom, R, Leggat, H, Tomura, HR, Hay, CR, Bone, JM. Plasma thrombomodulin in renal disease: effects of renal function and proteinuria. Clin Nephrol 1998; 50: 337-341.
17. Hergesell, O, Andrassy, K, Geberth, S, Nawroth, P, Gabath, S. Plasma thrombomodulin levels are dependent on renal function. Thromb Res 1993; 72: 455-458.
18. Tesar, V, Masek, Z, Rychilk, I, et al. Cytokines and adhesion molecules in renal vasculitis and lupus nephritis. Nephrol Dial Transplant 1998; 13: 1662-1667.
19. Blann, AD, Lip, GYH. The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications. Blood Coagul Fibrinolysis 1998; 9: 297-306.
20. Egerer, K, Feist, E, Rohr, U, Pruss, A, Burmester, G-R, Dorner, T. Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus 2000; 9: 614-621.
21. Nakatani, K, Fujii, H, Hasegawa, H, et al. Endothelial adhesion molecules in glomerular lesions: association with their severity and diversity in lupus models. Kidney Int 2004; 65: 1290-1300.
22. Mrowka, C, Sieberth, HG. Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener's granulomatosis, systemic lupus erythematosus and chronic renal failure. Clin Nephrol 1995; 43: 288-296.
23. Mrowka, C, Sieberth, HG. Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: marked differences between Wegner's granulomatosis and systemic lupus erythematosus. Clin Investig 1994; 72: 762-768.
24. Takaya, M, Ichikawa, Y, Kobayashi, N, et al. Serum thrombomodulin and anticardiolipin antibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1991; 9: 495-499.
25. Tomura, S, Deguchi, F, Marumo, F, et al. Enhanced presence of thrombomodulin in the glomeruli of lupus glomerulonephritis. Clin Nephrol 1994; 41: 205-210.